Friess Associates’s Clarivate CLVT Stock Holding History

Friess Associates’s Portfolio CLVT Stock Details CLVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-699,270	Closed	-$21.7M	–	101
2020 Q3	$21.7M	Buy	+699,270	New	+$18.9M	1.88%	15

Other funds holding CLVT

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Friess Associates's CLVT Position: Q4 2020 in Review

Friess Associates sold out of Clarivate (CLVT) in Q4 2020, closing a stake of 699,270 shares — an estimated $21.7M sold.

Friess Associates first reported a position in CLVT in Q3 2020 and held it in 1 quarter. The position peaked at $21.7M in Q3 2020. 198 funds tracked by Wall St. Rank hold CLVT as of Q4 2020.

Friess Associates reported no remaining Clarivate position as of Q4 2020 after selling out during the quarter.
Friess Associates sold 699,270 Clarivate shares in Q4 2020, an estimated $21.7M.
Friess Associates first reported a position in Clarivate in Q3 2020 and held it in 1 quarter.
Friess Associates's Clarivate position peaked at $21.7M in Q3 2020.
198 funds tracked by Wall St. Rank held Clarivate as of Q4 2020.

Based on Friess Associates's 13F filing for Q4 2020, filed 12 Feb 2021.